ENTITY
Legend Biotech Corp

Legend Biotech Corp (LEGN US)

100
Analysis
Health Care • China
Legend Biotech Corporation operates as a biopharmaceutical company. The Company engages in discovery and development of novel cell therapies for oncology and other indications. Legend Biotech serves customers in the State of New Jersey.
more
bullish•NetEase Inc
•24 May 2020 14:20

ECM Weekly (24 May 2020) - NetEase and JD Homecoming, Legend Biotech, Nongfu Spring, Yeahka

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. The talk...

Share
bullish•Legend Biotech Corp
•19 May 2020 12:14

Legend Biotech (ä¼ å„‡ē”Ÿē‰©) Pre-IPO: All-Stars Except for the Small Indication

Legend Biotech, a subsidiary of Hong Kong-listed GenScript, is planning to raise up to USD 300 million via an IPO. The company has a strong focus...

Logo
295 Views
Share
bullish•Legend Biotech Corp
•18 May 2020 15:32

Legend Biotech IPO Initiation: Choosing Therapies ƀ La CAR-T

Legend Biotech (BLG US) is one of the leading companies in developing CAR-T cell therapies in China, having received clearance for the first CAR-T...

Logo
315 Views
Share
x